 | • レポートコード：GIR201114698 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、100ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、オンコロジーベース前臨床CROの世界市場を調査対象にし、オンコロジーベース前臨床CROの市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（血液がん、固形がん、その他）、用途別分析（インビトロ、インビボ）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Crown Bioscience、The Jackson Laboratory、Eurofins Scientific、Charles River、EVOTEC、ICON、Champion Oncology、Covance、Taconic Biosciences、MI Bioresearch、Wuxi AppTec.、Xentech、Living Tumor Laboratory ・企業別売上、市場シェア ・オンコロジーベース前臨床CROの地域別市場分析 ・オンコロジーベース前臨床CROの北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・オンコロジーベース前臨床CROのヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・オンコロジーベース前臨床CROのアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・オンコロジーベース前臨床CROの南米市場規模2015-2020：ブラジル、アルゼンチンなど ・オンコロジーベース前臨床CROの中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・オンコロジーベース前臨床CROの種類別市場規模2015-2020：血液がん、固形がん、その他 ・オンコロジーベース前臨床CROの用途別市場規模2015-2020：インビトロ、インビボ ・オンコロジーベース前臨床CROの世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global Oncology Based Preclinical CRO market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.8% in the forecast period of 2020 to 2025 and will expected to reach USD 494.7 million by 2025, from USD 316.4 million in 2019.
The Oncology Based Preclinical CRO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Oncology Based Preclinical CRO market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Oncology Based Preclinical CRO market has been segmented into:
Blood Cancer
Solid Tumors
Others
By Application, Oncology Based Preclinical CRO has been segmented into:
In Vitro
In Vivo
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Oncology Based Preclinical CRO market presented in the report. This section sheds light on the sales growth of different regional and country-level Oncology Based Preclinical CRO markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Oncology Based Preclinical CRO market.
The report offers in-depth assessment of the growth and other aspects of the Oncology Based Preclinical CRO market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Oncology Based Preclinical CRO Market Share Analysis
Oncology Based Preclinical CRO competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Oncology Based Preclinical CRO sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Oncology Based Preclinical CRO sales, revenue and market share for each player covered in this report.
The major players covered in Oncology Based Preclinical CRO are:
Crown Bioscience
The Jackson Laboratory
Eurofins Scientific
Charles River
EVOTEC
ICON
Champion Oncology
Covance
Taconic Biosciences
MI Bioresearch
Wuxi AppTec.
Xentech
Living Tumor Laboratory
1 Oncology Based Preclinical CRO Market Overview
1.1 Product Overview and Scope of Oncology Based Preclinical CRO
1.2 Classification of Oncology Based Preclinical CRO by Type
1.2.1 Global Oncology Based Preclinical CRO Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Oncology Based Preclinical CRO Revenue Market Share by Type in 2019
1.2.3 Blood Cancer
1.2.4 Solid Tumors
1.2.5 Others
1.3 Global Oncology Based Preclinical CRO Market by Application
1.3.1 Overview: Global Oncology Based Preclinical CRO Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 In Vitro
1.3.3 In Vivo
1.4 Global Oncology Based Preclinical CRO Market by Regions
1.4.1 Global Oncology Based Preclinical CRO Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Oncology Based Preclinical CRO (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Oncology Based Preclinical CRO Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Oncology Based Preclinical CRO Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oncology Based Preclinical CRO Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Oncology Based Preclinical CRO Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oncology Based Preclinical CRO Status and Prospect (2015-2025)
2 Company Profiles
2.1 Crown Bioscience
2.1.1 Crown Bioscience Details
2.1.2 Crown Bioscience Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Crown Bioscience SWOT Analysis
2.1.4 Crown Bioscience Product and Services
2.1.5 Crown Bioscience Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.2 The Jackson Laboratory
2.2.1 The Jackson Laboratory Details
2.2.2 The Jackson Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 The Jackson Laboratory SWOT Analysis
2.2.4 The Jackson Laboratory Product and Services
2.2.5 The Jackson Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.3 Eurofins Scientific
2.3.1 Eurofins Scientific Details
2.3.2 Eurofins Scientific Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Eurofins Scientific SWOT Analysis
2.3.4 Eurofins Scientific Product and Services
2.3.5 Eurofins Scientific Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.4 Charles River
2.4.1 Charles River Details
2.4.2 Charles River Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Charles River SWOT Analysis
2.4.4 Charles River Product and Services
2.4.5 Charles River Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.5 EVOTEC
2.5.1 EVOTEC Details
2.5.2 EVOTEC Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 EVOTEC SWOT Analysis
2.5.4 EVOTEC Product and Services
2.5.5 EVOTEC Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.6 ICON
2.6.1 ICON Details
2.6.2 ICON Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 ICON SWOT Analysis
2.6.4 ICON Product and Services
2.6.5 ICON Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.7 Champion Oncology
2.7.1 Champion Oncology Details
2.7.2 Champion Oncology Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Champion Oncology SWOT Analysis
2.7.4 Champion Oncology Product and Services
2.7.5 Champion Oncology Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.8 Covance
2.8.1 Covance Details
2.8.2 Covance Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Covance SWOT Analysis
2.8.4 Covance Product and Services
2.8.5 Covance Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.9 Taconic Biosciences
2.9.1 Taconic Biosciences Details
2.9.2 Taconic Biosciences Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Taconic Biosciences SWOT Analysis
2.9.4 Taconic Biosciences Product and Services
2.9.5 Taconic Biosciences Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.10 MI Bioresearch
2.10.1 MI Bioresearch Details
2.10.2 MI Bioresearch Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 MI Bioresearch SWOT Analysis
2.10.4 MI Bioresearch Product and Services
2.10.5 MI Bioresearch Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.11 Wuxi AppTec.
2.11.1 Wuxi AppTec. Details
2.11.2 Wuxi AppTec. Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Wuxi AppTec. SWOT Analysis
2.11.4 Wuxi AppTec. Product and Services
2.11.5 Wuxi AppTec. Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.12 Xentech
2.12.1 Xentech Details
2.12.2 Xentech Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Xentech SWOT Analysis
2.12.4 Xentech Product and Services
2.12.5 Xentech Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
2.13 Living Tumor Laboratory
2.13.1 Living Tumor Laboratory Details
2.13.2 Living Tumor Laboratory Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Living Tumor Laboratory SWOT Analysis
2.13.4 Living Tumor Laboratory Product and Services
2.13.5 Living Tumor Laboratory Oncology Based Preclinical CRO Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Oncology Based Preclinical CRO Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Oncology Based Preclinical CRO Players Market Share
3.2.2 Top 10 Oncology Based Preclinical CRO Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Oncology Based Preclinical CRO Revenue and Market Share by Regions
4.2 North America Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
4.3 Europe Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
4.5 South America Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
5 North America Oncology Based Preclinical CRO Revenue by Countries
5.1 North America Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
5.2 USA Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
5.3 Canada Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
5.4 Mexico Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
6 Europe Oncology Based Preclinical CRO Revenue by Countries
6.1 Europe Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
6.2 Germany Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
6.3 UK Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
6.4 France Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
6.5 Russia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
6.6 Italy Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Oncology Based Preclinical CRO Revenue by Countries
7.1 Asia-Pacific Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
7.2 China Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
7.3 Japan Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
7.4 Korea Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
7.5 India Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
8 South America Oncology Based Preclinical CRO Revenue by Countries
8.1 South America Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
8.2 Brazil Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
8.3 Argentina Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Oncology Based Preclinical CRO by Countries
9.1 Middle East & Africa Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
9.2 Saudi Arabia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
9.3 UAE Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
9.4 Egypt Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
9.5 South Africa Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Oncology Based Preclinical CRO Revenue and Market Share by Type (2015-2020)
10.2 Global Oncology Based Preclinical CRO Market Forecast by Type (2019-2024)
10.3 Blood Cancer Revenue Growth Rate (2015-2025)
10.4 Solid Tumors Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global Oncology Based Preclinical CRO Market Segment by Application
11.1 Global Oncology Based Preclinical CRO Revenue Market Share by Application (2015-2020)
11.2 Oncology Based Preclinical CRO Market Forecast by Application (2019-2024)
11.3 In Vitro Revenue Growth (2015-2020)
11.4 In Vivo Revenue Growth (2015-2020)
12 Global Oncology Based Preclinical CRO Market Size Forecast (2021-2025)
12.1 Global Oncology Based Preclinical CRO Market Size Forecast (2021-2025)
12.2 Global Oncology Based Preclinical CRO Market Forecast by Regions (2021-2025)
12.3 North America Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
12.4 Europe Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
12.6 South America Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Oncology Based Preclinical CRO Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Oncology Based Preclinical CRO by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Oncology Based Preclinical CRO Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Oncology Based Preclinical CRO Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Crown Bioscience Corporate Information, Location and Competitors
Table 6. Crown Bioscience Oncology Based Preclinical CRO Major Business
Table 7. Crown Bioscience Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 8. Crown Bioscience SWOT Analysis
Table 9. Crown Bioscience Oncology Based Preclinical CRO Product and Solutions
Table 10. Crown Bioscience Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. The Jackson Laboratory Corporate Information, Location and Competitors
Table 12. The Jackson Laboratory Oncology Based Preclinical CRO Major Business
Table 13. The Jackson Laboratory Oncology Based Preclinical CRO Total Revenue (USD Million) (2018-2019)
Table 14. The Jackson Laboratory SWOT Analysis
Table 15. The Jackson Laboratory Oncology Based Preclinical CRO Product and Solutions
Table 16. The Jackson Laboratory Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Eurofins Scientific Corporate Information, Location and Competitors
Table 18. Eurofins Scientific Oncology Based Preclinical CRO Major Business
Table 19. Eurofins Scientific Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 20. Eurofins Scientific SWOT Analysis
Table 21. Eurofins Scientific Oncology Based Preclinical CRO Product and Solutions
Table 22. Eurofins Scientific Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Charles River Corporate Information, Location and Competitors
Table 24. Charles River Oncology Based Preclinical CRO Major Business
Table 25. Charles River Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 26. Charles River SWOT Analysis
Table 27. Charles River Oncology Based Preclinical CRO Product and Solutions
Table 28. Charles River Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. EVOTEC Corporate Information, Location and Competitors
Table 30. EVOTEC Oncology Based Preclinical CRO Major Business
Table 31. EVOTEC Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 32. EVOTEC SWOT Analysis
Table 33. EVOTEC Oncology Based Preclinical CRO Product and Solutions
Table 34. EVOTEC Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. ICON Corporate Information, Location and Competitors
Table 36. ICON Oncology Based Preclinical CRO Major Business
Table 37. ICON Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 38. ICON SWOT Analysis
Table 39. ICON Oncology Based Preclinical CRO Product and Solutions
Table 40. ICON Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Champion Oncology Corporate Information, Location and Competitors
Table 42. Champion Oncology Oncology Based Preclinical CRO Major Business
Table 43. Champion Oncology Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 44. Champion Oncology SWOT Analysis
Table 45. Champion Oncology Oncology Based Preclinical CRO Product and Solutions
Table 46. Champion Oncology Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Covance Corporate Information, Location and Competitors
Table 48. Covance Oncology Based Preclinical CRO Major Business
Table 49. Covance Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 50. Covance SWOT Analysis
Table 51. Covance Oncology Based Preclinical CRO Product and Solutions
Table 52. Covance Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Taconic Biosciences Corporate Information, Location and Competitors
Table 54. Taconic Biosciences Oncology Based Preclinical CRO Major Business
Table 55. Taconic Biosciences Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 56. Taconic Biosciences SWOT Analysis
Table 57. Taconic Biosciences Oncology Based Preclinical CRO Product and Solutions
Table 58. Taconic Biosciences Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. MI Bioresearch Corporate Information, Location and Competitors
Table 60. MI Bioresearch Oncology Based Preclinical CRO Major Business
Table 61. MI Bioresearch Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 62. MI Bioresearch SWOT Analysis
Table 63. MI Bioresearch Oncology Based Preclinical CRO Product and Solutions
Table 64. MI Bioresearch Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Wuxi AppTec. Corporate Information, Location and Competitors
Table 66. Wuxi AppTec. Oncology Based Preclinical CRO Major Business
Table 67. Wuxi AppTec. Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 68. Wuxi AppTec. SWOT Analysis
Table 69. Wuxi AppTec. Oncology Based Preclinical CRO Product and Solutions
Table 70. Wuxi AppTec. Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Xentech Corporate Information, Location and Competitors
Table 72. Xentech Oncology Based Preclinical CRO Major Business
Table 73. Xentech Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 74. Xentech SWOT Analysis
Table 75. Xentech Oncology Based Preclinical CRO Product and Solutions
Table 76. Xentech Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 77. Living Tumor Laboratory Corporate Information, Location and Competitors
Table 78. Living Tumor Laboratory Oncology Based Preclinical CRO Major Business
Table 79. Living Tumor Laboratory Oncology Based Preclinical CRO Total Revenue (USD Million) (2017-2018)
Table 80. Living Tumor Laboratory SWOT Analysis
Table 81. Living Tumor Laboratory Oncology Based Preclinical CRO Product and Solutions
Table 82. Living Tumor Laboratory Oncology Based Preclinical CRO Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 83. Global Oncology Based Preclinical CRO Revenue (Million USD) by Players (2015-2020)
Table 84. Global Oncology Based Preclinical CRO Revenue Share by Players (2015-2020)
Table 85. Global Oncology Based Preclinical CRO Revenue (Million USD) by Regions (2015-2020)
Table 86. Global Oncology Based Preclinical CRO Revenue Market Share by Regions (2015-2020)
Table 87. North America Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
Table 88. North America Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Table 89. Europe Oncology Based Preclinical CRO Revenue (Million USD) by Countries (2015-2020)
Table 90. Asia-Pacific Oncology Based Preclinical CRO Revenue (Million USD) by Countries (2015-2020)
Table 91. South America Oncology Based Preclinical CRO Revenue by Countries (2015-2020)
Table 92. South America Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Table 93. Middle East and Africa Oncology Based Preclinical CRO Revenue (Million USD) by Countries (2015-2020)
Table 94. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Table 95. Global Oncology Based Preclinical CRO Revenue (Million USD) by Type (2015-2020)
Table 96. Global Oncology Based Preclinical CRO Revenue Share by Type (2015-2020)
Table 97. Global Oncology Based Preclinical CRO Revenue Forecast by Type (2021-2025)
Table 98. Global Oncology Based Preclinical CRO Revenue by Application (2015-2020)
Table 99. Global Oncology Based Preclinical CRO Revenue Share by Application (2015-2020)
Table 100. Global Oncology Based Preclinical CRO Revenue Forecast by Application (2021-2025)
Table 101. Global Oncology Based Preclinical CRO Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Oncology Based Preclinical CRO Picture
Figure 2. Global Oncology Based Preclinical CRO Revenue Market Share by Type in 2019
Figure 3. Blood Cancer Picture
Figure 4. Solid Tumors Picture
Figure 5. Others Picture
Figure 6. Oncology Based Preclinical CRO Revenue Market Share by Application in 2019
Figure 7. In Vitro Picture
Figure 8. In Vivo Picture
Figure 9. Global Oncology Based Preclinical CRO Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Oncology Based Preclinical CRO Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Oncology Based Preclinical CRO Revenue Market Share in 2019
Figure 18. Global Top 10 Players Oncology Based Preclinical CRO Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Oncology Based Preclinical CRO Revenue Market Share by Regions (2015-2020)
Figure 22. Global Oncology Based Preclinical CRO Revenue Market Share by Regions in 2018
Figure 23. North America Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 24. Europe Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 26. South America Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 28. North America Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Figure 29. North America Oncology Based Preclinical CRO Revenue Market Share by Countries in 2019
Figure 30. USA Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 31. Canada Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 33. Europe Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Oncology Based Preclinical CRO Revenue Market Share by Countries in 2019
Figure 35. Germany Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 36. UK Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 37. France Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 38. Russia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 39. Italy Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Share by Countries in 2019
Figure 42. China Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 43. Japan Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 44. Korea Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 45. India Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 47. South America Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Figure 48. South America Oncology Based Preclinical CRO Revenue Market Share by Countries in 2019
Figure 49. Brazil Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 54. UAE Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Oncology Based Preclinical CRO Revenue and Growth Rate (2015-2020)
Figure 57. Global Oncology Based Preclinical CRO Revenue Share by Type (2015-2020)
Figure 58. Global Oncology Based Preclinical CRO Revenue Share by Type in 2019
Figure 59. Global Oncology Based Preclinical CRO Market Share Forecast by Type (2021-2025)
Figure 60. Global Blood Cancer Revenue Growth Rate (2015-2020)
Figure 61. Global Solid Tumors Revenue Growth Rate (2015-2020)
Figure 62. Global Others Revenue Growth Rate (2015-2020)
Figure 63. Global Oncology Based Preclinical CRO Revenue Share by Application (2015-2020)
Figure 64. Global Oncology Based Preclinical CRO Revenue Share by Application in 2019
Figure 65. Global Oncology Based Preclinical CRO Market Share Forecast by Application (2021-2025)
Figure 66. Global In Vitro Revenue Growth Rate (2015-2020)
Figure 67. Global In Vivo Revenue Growth Rate (2015-2020)
Figure 68. Global Oncology Based Preclinical CRO Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Oncology Based Preclinical CRO Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Oncology Based Preclinical CRO Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
Figure 72. Europe Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
Figure 74. South America Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Oncology Based Preclinical CRO Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
免疫腫瘍学の世界市場 2020年 Market Overview The global Immuno-Oncology market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 14.3% in the forecast period of 2020 to 2025 and will expected to reach USD 56950 million by 2025, from USD 33390 million in 2019. The Immuno-Oncology marke…- 免疫腫瘍学治療の世界市場 2020年 Market Overview The global Immuno-Oncology Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Immuno-Oncology Tre…
- オンコロジージェネリック注射薬の世界市場 2020年 Market Overview The global Oncology Generic Injectable Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Oncology Ge…
- 細胞ベースヒト化マウスモデルの世界市場 2020年 Market Overview The global Cell-based Humanized Mouse Models market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cell-based …
- インターベンショナル腫瘍デバイスの世界市場 2020年 Market Overview The Interventional Oncology Device market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…